These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 7655333)

  • 1. A longitudinal analysis of human papillomavirus 16 infection, nutritional status, and cervical dysplasia progression.
    Liu T; Soong SJ; Alvarez RD; Butterworth CE
    Cancer Epidemiol Biomarkers Prev; 1995 Jun; 4(4):373-80. PubMed ID: 7655333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up.
    Branca M; Garbuglia AR; Benedetto A; Cappiello T; Leoncini L; Migliore G; Agarossi A; Syrjänen K;
    Int J STD AIDS; 2003 Jun; 14(6):417-25. PubMed ID: 12816671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association of plasma micronutrients with the risk of cervical dysplasia in Hawaii.
    Goodman MT; Kiviat N; McDuffie K; Hankin JH; Hernandez B; Wilkens LR; Franke A; Kuypers J; Kolonel LN; Nakamura J; Ing G; Branch B; Bertram CC; Kamemoto L; Sharma S; Killeen J
    Cancer Epidemiol Biomarkers Prev; 1998 Jun; 7(6):537-44. PubMed ID: 9641499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of risk factors associated with human papillomavirus infection in women living with HIV. Canadian Women's HIV Study Group.
    Hankins C; Coutlée F; Lapointe N; Simard P; Tran T; Samson J; Hum L
    CMAJ; 1999 Jan; 160(2):185-91. PubMed ID: 9951439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of the Digene Hybrid Capture System for identification of the human papillomavirus (HPV-Human Papillomavirus) in women with cervical dysplasia].
    Kwaśniewska A; Semczuk M; Sikorski M; Kraczkowski J
    Przegl Lek; 1997; 54(12):848-50. PubMed ID: 9591452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for cervical neoplasia in Denmark.
    Kjaer SK
    APMIS Suppl; 1998; 80():1-41. PubMed ID: 9693662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune activation in cervical neoplasia: cross-sectional association between plasma soluble interleukin 2 receptor levels and disease.
    Hildesheim A; Schiffman MH; Tsukui T; Swanson CA; Lucci J; Scott DR; Glass AG; Rush BB; Lorincz AT; Corrigan A; Burk RD; Helgesen K; Houghten RA; Sherman ME; Kurman RJ; Berzofsky JA; Kramer TR
    Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):807-13. PubMed ID: 9332763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papillomavirus persistence and nutrients involved in the methylation pathway among a cohort of young women.
    Sedjo RL; Inserra P; Abrahamsen M; Harris RB; Roe DJ; Baldwin S; Giuliano AR
    Cancer Epidemiol Biomarkers Prev; 2002 Apr; 11(4):353-9. PubMed ID: 11927495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HPV testing in the evaluation of the minimally abnormal Papanicolaou smear.
    Apgar BS; Brotzman G
    Am Fam Physician; 1999 May; 59(10):2794-801. PubMed ID: 10348071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus absence predicts normal cervical histopathologic findings with abnormal papanicolaou smears: a study of a university-based inner city population.
    Khanna N; Brooks SE; Chen TT; Simsir A; Gordon NJ; Taylor G
    J Hum Virol; 2001; 4(5):283-7. PubMed ID: 11907386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunocytochemical staining of p16INK4a protein from conventional Pap test and its association with human papillomavirus infection.
    Pientong C; Ekalaksananan T; Kongyingyoes B; Kritpetcharat O; Swadpanich U; Pengsa P; Yuenyao P
    Diagn Cytopathol; 2004 Oct; 31(4):235-42. PubMed ID: 15452898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of human papillomavirus (HPV) load and type in high-grade cervical lesions surgically resected from HIV-infected women during follow-up of HPV infection.
    Lillo FB; Lodini S; Ferrari D; Stayton C; Taccagni G; Galli L; Lazzarin A; Uberti-Foppa C
    Clin Infect Dis; 2005 Feb; 40(3):451-7. PubMed ID: 15668870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma ascorbic acid and beta-carotene levels in women evaluated for HPV infection, smoking, and cervix dysplasia.
    Basu J; Palan PR; Vermund SH; Goldberg GL; Burk RD; Romney SL
    Cancer Detect Prev; 1991; 15(3):165-70. PubMed ID: 1647869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folate, vitamin B12, and homocysteine status. findings of no relation between human papillomavirus persistence and cervical dysplasia.
    Sedjo RL; Fowler BM; Schneider A; Henning SM; Hatch K; Giuliano AR
    Nutrition; 2003 Jun; 19(6):497-502. PubMed ID: 12781848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The management of minor degrees of cervical dysplasia associated with the human papilloma virus.
    Carmichael JA
    Yale J Biol Med; 1991; 64(6):591-7. PubMed ID: 1667239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folate deficiency and cervical dysplasia.
    Butterworth CE; Hatch KD; Macaluso M; Cole P; Sauberlich HE; Soong SJ; Borst M; Baker VV
    JAMA; 1992 Jan 22-29; 267(4):528-33. PubMed ID: 1729576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary factors in women with dysplasia colli uteri associated with human papillomavirus infection.
    Kwaśniewska A; Charzewska J; Tukendorf A; Semczuk M
    Nutr Cancer; 1998; 30(1):39-45. PubMed ID: 9507511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HPV DNA positivity and natural killer cell activity in the clinical outcome of mild cervical dysplasia: integration between virus and immune system.
    Garzetti GG; Ciavattini A; Goteri G; De Nictolis M; Menso S; Muzzioli M; Fabris N
    Gynecol Obstet Invest; 1995; 39(2):130-5. PubMed ID: 7737583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contraceptive and reproductive risks for cervical dysplasia in southwestern Hispanic and non-Hispanic white women.
    Becker TM; Wheeler CM; McGough NS; Stidley CA; Parmenter CA; Dorin MH; Jordan SW
    Int J Epidemiol; 1994 Oct; 23(5):913-22. PubMed ID: 7860171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical fingerprints of human papillomavirus infection and cervical dysplasia using cervical fluids: Spectral pattern investigation.
    Kim YH; Chang B; Choi JH; Park HK; Choi S
    Microsc Res Tech; 2016 Oct; 79(10):966-972. PubMed ID: 27435509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.